Industry News

Sep 04, 2018
By BioPharm International Editors
As it investigates the root cause of an impurity discovered in valsartan, FDA extends its studies to APIs with similar synthesis processes.
Sep 01, 2018
BioPharm International
More consistent and reliable production processes are critical for advancing innovative treatments.
Aug 31, 2018
By BioPharm International Editors
Alcami and the University of North Carolina Wilmington received a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals to prepare students for careers in pharmaceutical sciences.
Aug 30, 2018
By BioPharm International Editors
Girish Malhotra argues in CPhI Annual Report that shorter approval times and financial incentives are needed to promote manufacturing improvements.
Aug 29, 2018
By BioPharm International Editors
Bristol-Myers Squibb appointed a new executive vice-president and chief commercial officer from within the company, effective immediately.
Aug 29, 2018
By BioPharm International Editors
PDA Technical Report 80 (TR 80): Data Integrity in Laboratory Systems is the first in a series of three technical reports PDA will publish on data integrity.
Aug 28, 2018
By BioPharm International Editors
Preliminary survey results rank the United States, Germany, and Japan as tier-one nations for bioprocessing performance and potential.
Aug 27, 2018
The Senate approved a $159-million budget increase for FDA, to bring its resources up to $5.4 billion for 2019, including more than $2 billion in user fees.
Aug 27, 2018
By BioPharm International Editors
The Coalition for Epidemic Preparedness Innovations (CEPI) and vaccine manufacturer IDT Biologika will collaborate to develop and manufacture a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
Aug 24, 2018
By BioPharm International Editors
FDA sent a warning letter to Kyowa Hakko Bio Co., Ltd. after inspectors found data integrity problems at the company’s Yamaguchi, Japan facility.
native1_300x100
lorem ipsum